Hyperthermic intraperitoneal chemotherapy for patients with gastric cancer based on laboratory tests is safe: a single Chinese center analysis

PURPOSE: About 15%—40% of gastric cancer patients have peritoneal metastasis, which leads to poor prognosis. Hyperthermic intraperitoneal chemotherapy (HIPEC) is considered to be an effective treatment for these patients. This study evaluated the efficacy and safety of HIPEC in patients with gastric...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yunzi, Zheng, Xiaohao, Sun, Chunyang, Wang, Shenghui, Ding, Shikang, Wu, Ming, Zhang, Jing, Wang, Bingzhi, Xue, Liyan, Yang, Lin, Tian, Yantao, Xie, Yibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482732/
https://www.ncbi.nlm.nih.gov/pubmed/36115993
http://dx.doi.org/10.1186/s12893-022-01795-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482732/
https://www.ncbi.nlm.nih.gov/pubmed/36115993
http://dx.doi.org/10.1186/s12893-022-01795-6

Ejemplares similares